» Articles » PMID: 34909561

Human Exposome Assessment Platform

Abstract

The Human Exposome Assessment Platform (HEAP) is a research resource for the integrated and efficient management and analysis of human exposome data. The project will provide the complete workflow for obtaining exposome actionable knowledge from population-based cohorts. HEAP is a state-of-the-science service composed of computational resources from partner institutions, accessed through a software framework that provides the world's fastest Hadoop platform for data warehousing and applied artificial intelligence (AI). The software, will provide a decision support system for researchers and policymakers. All the data managed and processed by HEAP, together with the analysis pipelines, will be available for future research. In addition, the platform enables adding new data and analysis pipelines. HEAP's final product can be deployed in multiple instances to create a network of shareable and reusable knowledge on the impact of exposures on public health.

Citing Articles

Rethinking the rise of early-onset gastrointestinal cancers: a call to action.

Weinberg B, Murphy C, Freyer D, Greathouse K, Blancato J, Stoffel E JNCI Cancer Spectr. 2025; 9(1).

PMID: 39814070 PMC: 11804804. DOI: 10.1093/jncics/pkaf002.


Multi-omics approach in gut and environmental microbiota research under the One Health concept.

Kostka A, Gruszecka-Kosowska A, Ruiz-Rodriguez A, Aguilera M EFSA J. 2024; 22(Suppl 1):e221104.

PMID: 39712914 PMC: 11659745. DOI: 10.2903/j.efsa.2024.e221104.


Reconceptualizing and Defining Exposomics within Environmental Health: Expanding the Scope of Health Research.

Safarlou C, Jongsma K, Vermeulen R Environ Health Perspect. 2024; 132(9):95001.

PMID: 39331035 PMC: 11430758. DOI: 10.1289/EHP14509.


The Chilean exposome-based system for ecosystems (CHiESS): a framework for national data integration and analytics platform.

Matus P, Sepulveda-Penaloza A, Page K, Rodriguez C, Carcamo M, Bustamante F Front Public Health. 2024; 12:1407514.

PMID: 39114513 PMC: 11303229. DOI: 10.3389/fpubh.2024.1407514.


The Swedish Cervical Screening Cohort.

Dillner J, Arroyo Muhr L, Kleppe S, Wang J, Andersson H, Elfstrom M Sci Data. 2024; 11(1):697.

PMID: 38926412 PMC: 11208431. DOI: 10.1038/s41597-024-03519-2.


References
1.
Lehtinen M, Surcel H, Natunen K, Pukkala E, Dillner J . Cancer Registry follow-up for 17 million person-years of a nationwide maternity cohort. Cancer Med. 2017; 6(12):3060-3064. PMC: 5727241. DOI: 10.1002/cam4.1222. View

2.
Basu P, Ponti A, Anttila A, Ronco G, Senore C, Vale D . Status of implementation and organization of cancer screening in The European Union Member States-Summary results from the second European screening report. Int J Cancer. 2017; 142(1):44-56. DOI: 10.1002/ijc.31043. View

3.
Tang W, Aggarwal A, Vernez Moudon A, Drewnowski A . Self-reported and measured weights and heights among adults in Seattle and King County. BMC Obes. 2016; 3:11. PMC: 4757992. DOI: 10.1186/s40608-016-0088-2. View

4.
Fogelberg S, Clements M, Pedersen K, Sy S, Sparen P, Kim J . Cost-effectiveness of cervical cancer screening with primary HPV testing for unvaccinated women in Sweden. PLoS One. 2020; 15(9):e0239611. PMC: 7526933. DOI: 10.1371/journal.pone.0239611. View

5.
Eklund N, Andrianarisoa N, van Enckevort E, Anton G, Debucquoy A, Muller H . Extending the Minimum Information About BIobank Data Sharing Terminology to Describe Samples, Sample Donors, and Events. Biopreserv Biobank. 2020; 18(3):155-164. PMC: 7310316. DOI: 10.1089/bio.2019.0129. View